• Nuts are good sources of fiber, phytosterols, and unsaturated fat. (More information)
  • The results of most prospective cohort studies suggest that regular nut consumption (equivalent to 1 oz at least five times weekly) is associated with a significantly lower risk of cardiovascular disease. (More information)
  • One prospective cohort study has found that regular nut consumption is associated with significantly lower risk of developing type 2 diabetes. (More information)
  • Most prospective studies have shown that people who consume nuts regularly weigh less than those who rarely consume nuts. Nonetheless, since an ounce of most nuts provides about 160 kcal of energy, substituting nuts for other less healthy snacks is a good strategy for avoiding weight gain when increasing nut intake. (More information)


In the not too distant past, nuts were considered unhealthy because of their relatively high fat content. In contrast, recent research suggests that regular nut consumption is an important part of a healthful diet (1). Although the fat content of nuts is relatively high (14-19 grams/ounce), most of the fats in nuts are the healthier, monounsaturated and polyunsaturated fats (see Table 1(2). The term “nuts” includes almonds, Brazil nuts, cashews, hazelnuts, macadamia nuts, pecans, pistachios, walnuts, and peanuts. Despite their name, peanuts are actually legumes like peas and beans. However, they are nutritionally similar to tree nuts and have some of the same beneficial properties.

Disease Prevention

Cardiovascular disease

Coronary heart disease

In large prospective cohort studies, regular nut consumption has been consistently associated with significant reductions in the risk of coronary heart disease (CHD) (3). One of the first studies to observe a protective effect of nut consumption was the Adventist Health Study, which followed more than 30,000 Seventh Day Adventists over 12 years (4). In general, the dietary and lifestyle habits of Seventh Day Adventists are closer to those recommended for cardiovascular disease prevention than those of average Americans. Few of those who participated in the Adventist Health Study smoked, and most consumed a diet lower in saturated fat than the average American. In this healthy group, those who consumed nuts at least five times weekly had a 48% lower risk of death from CHD and a 51% lower risk of a nonfatal myocardial infarction (MI) compared to those who consumed nuts less than once weekly (4). In Seventh Day Adventists who were older than 83 years of age, those who ate nuts at least five times weekly had a risk of death from CHD that was 39% lower than those who consumed nuts less than once weekly (5). A smaller prospective study of more than 3,000 Black men and women reported similar results (6). Those who consumed nuts at least five times weekly had a risk of death from CHD that was 44% lower than those who consumed nuts less than once weekly (6).

The cardioprotective effects of nuts are not limited to Seventh Day Adventists. In a 14-year study of more than 86,000 women participating in the Nurses’ Health Study, those who consumed more than 5 oz of nuts weekly had a risk of CHD that was 35% lower than those who ate less than 1 oz of nuts monthly (7). Similar decreases were observed for the risk of nonfatal MI and death from CHD. More recently, a 17-year study of more than 21,000 male physicians found that those who consumed nuts at least twice weekly had a risk of sudden cardiac death that was 53% lower than those who rarely or never consumed nuts, although there was no significant decrease in the risk of nonfatal MI or nonsudden CHD death (8). A follow-up analysis in this cohort of male physicians found that nut consumption was not associated with incident heart failure (9). The Iowa Women’s Health Study, which followed more than 30,000 postmenopausal women for 12 years, is the only published prospective study that did not observe a significant inverse association between nut consumption and CHD mortality, although a slight but significant decrease in all-cause mortality was observed in those who consumed nuts twice weekly (10). Overall, the results of most prospective cohort studies suggest that regular nut consumption is associated with a substantial decrease in the risk of death related to CHD. In fact, a recent pooled analysis of four of the US epidemiological studies mentioned above found those with the highest intake of nuts (about 5 times per week) had a 35% lower risk of CHD (11).

Results of controlled clinical trials indicate that at least part of the cardioprotective effect of nuts is derived from beneficial effects on serum total and LDL cholesterol concentrations (3). At least 18 controlled clinical trials have found that adding nuts to a diet that is low in saturated fat results in significantly reductions in serum total cholesterol and LDL cholesterol concentrations in people with normal or elevated serum cholesterol. These effects have been observed for almonds (12-15), hazelnuts (16), macadamia nuts (17-19), peanuts (20, 21), pecans (22), pistachio nuts (23, 24) and walnuts (25-30). More recently, a cross-sectional study found that frequent nut and seed consumption was associated with lower serum levels of inflammatory biomarkers in a multi-ethnic population (31). Although the evidence is circumstantial, these findings suggest that compounds in nuts may lower the risk of cardiovascular disease by decreasing inflammation.

Cardioprotective compounds in nuts

Substituting dietary saturated fats with polyunsaturated and monounsaturated fats like those found in nuts can decrease serum total and LDL cholesterol concentrations (3). However, in some clinical trials, the cholesterol-lowering effect of nut consumption was greater than would be predicted from the polyunsaturated and monounsaturated fat content of the nuts, suggesting there may be other protective factors in nuts (32). Other bioactive compounds in nuts that may contribute to their cholesterol-lowering effects include fiber and phytosterols (33). See  Table 1 for the unsaturated fat, fiber, and phytosterol content of selected nuts. Walnuts are especially rich in alpha-linolenic acid, an omega-3 fatty acid with a number of cardioprotective effects, including the prevention of cardiac arrhythmias that may lead to sudden cardiac death. Other nutrients that may contribute to the cardioprotective effects of nuts include folate, vitamin E, and potassium (3, 33-35). The US Food and Drug Administration (FDA) has acknowledged the emerging evidence for a relationship between nut consumption and cardiovascular disease risk by approving the following qualified health claim for nuts (36): “Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease.” For more information on the nutrient content of nuts, search the USDA National Nutrient Database.

Table 1. Energy, Fat, Phytosterols and Fiber in a 1-oz Serving of Selected Nuts
(1 ounce)
Energy (kcal) Total Fat (g) MUFA* (g) PUFA* (g) Phytosterols (mg) Fiber (g)
Brazil nuts
Macadamia nuts
Peanuts (legume)
Peanut butter, smooth (2 Tbsp)
Pine nuts (pignoli)
Pistachio nuts
Walnuts, Black
*MUFA, Monounsaturated Fatty Acids; PUFA, Polyunsaturated Fatty Acids

Type 2 diabetes mellitus

Recent results from the Nurses’ Health Study suggest that nut and peanut butter consumption may be inversely associated with the risk of type 2 diabetes mellitus (DM) in women (37). In this cohort of more than 86,000 women followed over 16 years, those who consumed an ounce of nuts at least five times weekly had a risk of developing type 2 DM that was 27% lower than those who rarely or never consumed nuts. Similarly those who consumed peanut butter at least five times weekly had a risk of developing type 2 DM that was 21% lower than those who rarely or never consumed peanut butter. While these findings require confirmation in other studies, they provide additional evidence that nuts can be a component of a healthful diet. Compounds in nuts that could contribute to the observed decrease in type 2 DM include unsaturated fats, fiber, and magnesium.

Overweight and obesity

A major concern is that increased consumption of nuts may cause weight gain and obesity. However, several cross-sectional analyses of large cohort studies, including the Adventist Health Study (5) and the Nurses' Health Study (7), have shown that individuals who consume nuts regularly tend to weigh less than those who rarely consume them. Recently, a 28-month prospective study conducted in Spain found that participants who consumed higher amount of nuts had lower risk of weight gain than those who rarely ate nuts (38). A similar association was observed in the Nurses' Health Study II (39). These epidemiological data indicate that in free-living subjects, higher nut consumption does not cause greater weight gain; rather, incorporating nuts into diets may be beneficial for weight control. It is possible that higher amounts of protein and fiber in nuts enhance satiety and suppress hunger.


Nut allergies

Allergies to peanuts and tree nuts (almonds, cashews, hazelnuts, pecans, pistachios, and walnuts) are among the most common food allergies, affecting at least 1% of the US population (40). Although all food allergies have the potential to induce severe reactions, peanuts and tree nuts are among the foods most commonly associated with anaphylaxis, a life-threatening allergic reaction (41). People with severe peanut or tree nut allergies need to take special precautions to avoid inadvertently consuming peanuts or tree nuts by checking labels and avoiding unlabeled snacks, candies, and desserts. See the Food Allergy and Anaphylaxis Network website for additional tips to avoiding unintentional peanut or tree nut exposure.

Adverse effects

Brazil nuts grown in areas of Brazil with selenium-rich soil may provide more than 100 mcg of selenium in one nut, while those grown in selenium-poor soil may provide ten times less (42). For information regarding toxicity of selenium, see the article on Selenium.

Intake Recommendations

Regular nut consumption, equivalent to an ounce of nuts five times weekly, has been consistently associated with significant reductions in coronary heart disease (CHD) risk in epidemiological studies. Consuming 1-2 oz of nuts daily as part of a diet that is low in saturated fat has been found to lower serum total and LDL cholesterol in a number of controlled clinical trials. Since an ounce of most nuts provides at least 160 calories (kcal), simply adding an ounce of nuts daily to one’s habitual diet without eliminating other foods may result in weight gain. Substituting unsalted nuts for other less healthy snacks or for meat in main dishes are two ways to make nuts part of a healthful diet. Table 2 lists some potentially beneficial compounds in nuts.

Table 2. Some Potentially Beneficial Compounds in Nuts
Macronutrients Vitamins Minerals Phytochemicals
Unsaturated Fats Folate Magnesium Fiber
  Vitamin E Potassium Phytosterols

Authors and Reviewers

Originally written in 2003 by:
Jane Higdon, Ph.D.
Linus Pauling Institute
Oregon State University

Updated in December 2005 by:
Jane Higdon, Ph.D.
Linus Pauling Institute
Oregon State University

Updated in June 2009 by:
Victoria J. Drake, Ph.D.
Linus Pauling Institute
Oregon State University

Reviewed in June 2009 by:
Frank B. Hu, M.D., Ph.D.
Professor of Nutrition and Epidemiology
Harvard School of Public Health

Copyright 2003-2015  Linus Pauling Institute 


1.  Hu FB, Stampfer MJ. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Curr Atheroscler Rep. 1999;1(3):204-209.  (PubMed)

2.  Kris-Etherton PM, Yu-Poth S, Sabate J, Ratcliffe HE, Zhao G, Etherton TD. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr. 1999;70(3 Suppl):504S-511S.  (PubMed)

3.  Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD. The effects of nuts on coronary heart disease risk. Nutr Rev. 2001;59(4):103-111.  (PubMed)

4.  Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med. 1992;152(7):1416-1424.  (PubMed)

5.  Fraser GE, Shavlik DJ. Risk factors for all-cause and coronary heart disease mortality in the oldest-old. The Adventist Health Study. Arch Intern Med. 1997;157(19):2249-2258.  (PubMed)

6.  Fraser GE, Sumbureru D, Pribis P, Neil RL, Frankson MA. Association among health habits, risk factors, and all-cause mortality in a black California population. Epidemiology. 1997;8(2):168-174.  (PubMed)

7.  Hu FB, Stampfer MJ, Manson JE, et al. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ. 1998;317(7169):1341-1345.  (PubMed)

8.  Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002;162(12):1382-1387.  (PubMed)

9.  Djousse L, Rudich T, Gaziano JM. Nut consumption and risk of heart failure in the Physicians' Health Study I. Am J Clin Nutr. 2008;88(4):930-933.  (PubMed)

10.  Ellsworth JL, Kushi LH, Folsom AR. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women's Health Study. Nutr Metab Cardiovasc Dis. 2001;11(6):372-377.   (PubMed)

11.  Kris-Etherton PM, Hu FB, Ros E, Sabate J. The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms. J Nutr. 2008;138(9):1746S-1751S.  (PubMed)

12.  Hyson DA, Schneeman BO, Davis PA. Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J Nutr. 2002;132(4):703-707.  (PubMed)

13.  Jenkins DJ, Kendall CW, Marchie A, et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation. 2002;106(11):1327-1332.  (PubMed)

14.  Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr. 2003;77(6):1379-1384.  (PubMed)

15.  Spiller GA, Jenkins DA, Bosello O, Gates JE, Cragen LN, Bruce B. Nuts and plasma lipids: an almond-based diet lowers LDL-C while preserving HDL-C. J Am Coll Nutr. 1998;17(3):285-290.  (PubMed)

16.  Durak I, Koksal I, Kacmaz M, Buyukkocak S, Cimen BM, Ozturk HS. Hazelnut supplementation enhances plasma antioxidant potential and lowers plasma cholesterol levels. Clin Chim Acta. 1999;284(1):113-115.

17.  Curb JD, Wergowske G, Dobbs JC, Abbott RD, Huang B. Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. Arch Intern Med. 2000;160(8):1154-1158.  (PubMed)

18.  Garg ML, Blake RJ, Wills RB. Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. J Nutr. 2003;133(4):1060-1063.  (PubMed)

19.  Griel AE, Cao Y, Bagshaw DD, Cifelli AM, Holub B, Kris-Etherton PM. A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. J Nutr. 2008;138(4):761-767.  (PubMed)

20.  Kris-Etherton PM, Pearson TA, Wan Y, et al. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr. 1999;70(6):1009-1015.  (PubMed)

21.  O'Byrne DJ, Knauft DA, Shireman RB. Low fat-monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles. Lipids. 1997;32(7):687-695.  (PubMed)

22.  Morgan WA, Clayshulte BJ. Pecans lower low-density lipoprotein cholesterol in people with normal lipid levels. J Am Diet Assoc. 2000;100(3):312-318.  (PubMed)

23.  Edwards K, Kwaw I, Matud J, Kurtz I. Effect of pistachio nuts on serum lipid levels in patients with moderate hypercholesterolemia. J Am Coll Nutr. 1999;18(3):229-232.  (PubMed)

24. Sheridan MJ, Cooper JN, Erario M, Cheifetz CE. Pistachio nut consumption and serum lipid levels. J Am Coll Nutr. 2007;26(2):141-148.  (PubMed)

25.  Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am J Clin Nutr. 1994;59(5):995-999.   (PubMed)

26.  Almario RU, Vonghavaravat V, Wong R, Kasim-Karakas SE. Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr. 2001;74(1):72-79.  (PubMed)

27.  Chisholm A, Mann J, Skeaff M, et al. A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects. Eur J Clin Nutr. 1998;52(1):12-16.  (PubMed)

28.  Morgan JM, Horton K, Reese D, Carey C, Walker K, Capuzzi DM. Effects of walnut consumption as part of a low-fat, low-cholesterol diet on serum cardiovascular risk factors. Int J Vitam Nutr Res. 2002;72(5):341-347.  (PubMed)

29.  Sabate J, Fraser GE, Burke K, Knutsen SF, Bennett H, Lindsted KD. Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med. 1993;328(9):603-607.  (PubMed)

30.  Zambon D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med. 2000;132(7):538-546.  (PubMed)

31.  Jiang R, Jacobs DR, Jr., Mayer-Davis E, et al. Nut and Seed Consumption and Inflammatory Markers in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2005;163(3):222-31.  (PubMed)

32.  Coulston AM. Do Nuts Have a Place in a Healthful Diet? Nutr Today. 2003;38(3):95-99.  (PubMed)

33.  Segura R, Javierre C, Lizarraga MA, Ros E. Other relevant components of nuts: phytosterols, folate and minerals. Br J Nutr. 2006;96 Suppl 2:S36-44.  (PubMed)

34.  Willett WC. Eat, Drink, and be Healthy: The Harvard Medical School Guide to Healthy Eating. New York: Simon & Schuster; 2001.

35.  Coates AM, Howe PR. Edible nuts and metabolic health. Curr Opin Lipidol. 2007;18(1):25-30.  (PubMed)

36.  US Food and Drug Administration, Center for Food Safety and Nutrition. Summary of Qualified Health Claims Subject to Enforcement Discretion. 2003. Available at:

37.  Jiang R, Manson JE, Stampfer MJ, Liu S, Willett WC, Hu FB. Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA. 2002;288(20):2554-2560.  (PubMed)

38.  Bes-Rastrollo M, Sabate J, Gomez-Gracia E, Alonso A, Martinez JA, Martinez-Gonzalez MA. Nut consumption and weight gain in a Mediterranean cohort: The SUN study. Obesity (Silver Spring). 2007;15(1):107-116.  (PubMed)

39.  Bes-Rastrollo M, Wedick NM, Martinez-Gonzalez MA, Li TY, Sampson L, Hu FB. Prospective study of nut consumption, long-term weight change, and obesity risk in women. Am J Clin Nutr. 2009;89(6):1913-1919.  (PubMed)

40.  Sicherer SH, Munoz-Furlong A, Burks AW, Sampson HA. Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol. 1999;103(4):559-562.  (PubMed)

41.  Al-Muhsen S, Clarke AE, Kagan RS. Peanut allergy: an overview. CMAJ. 2003;168(10):1279-1285.  (PubMed)

42.  Chang JC. Selenium content of Brazil nuts from two geographic locations in Brazil. Chemosphere. 1995;30:801-802.  (PubMed)